Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present new data in scientific posters to be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will be held online, April 10-15, 2021 and May 17-21, 2021.
These abstracts showcase data from ImmunoID NeXT, the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The ImmunoID NeXT Platform can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.
Following are details and links to the scientific posters that will be presented at the online meeting.
|
Poster Number, Session Category and Session Title |
Title & Presenter |
Date |
Location |
|
399 Clinical Research (Excluding Trials)
Biomarkers Predictive of Therapeutic Benefit |
Pan-cancer survey of HLA loss of heterozygosity using a robustly validated NGS-based machine learning algorithm
Presenter: Rachel Marty Pyke, PhD
|
April 10, 2021 |
|
|
555 Clinical Research (Excluding Trials)
Liquid Biopsies: Circulating DNA |
Longitudinal exome-scale liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy
Presenter: Charles Abbott, PhD |
April 10, 2021 |
|
|
1898
Immunology
Antigenicity/Processing and Presentation |
Accurate modeling of antigen processing and MHC peptide presentation using large-scale immunopeptidomes and a novel machine learning framework |
Diesen Artikel teilen
